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Electrophoretic behavior of streptavidin complexed
to a biotinylated probe: A functional screening
assay for biotin-binding proteins
Thebiotin-bindingprotein streptavidinexhibits a highstability against thermal denaturation,
especially when complexed to biotin. Herein we show that, in sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), streptavidin is stabilized at high tempera-
ture in the presence of biotinylated fluorescent probes, such as biotin-4-fluorescein, which
is incorporated within the binding pocket. In nondenaturing SDS-PAGE, streptavidin is
detectable when complexed with biotin-4-fluorescein using a UV-transilluminator. Using
biotin-4-fluorescein, the detection limit of streptavidin lies in the same range as with Coo-
massieblue staining. The functionality of streptavidinmutantscan readily be assessed from
crude bacterial extracts using biotin-4-fluorescein as a probe innondenaturingSDS-PAGE.
Keywords: Biotin-4-fluorescein / Functional screening / Nondenaturing sodium dodecyl sulfate-
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1 Introduction
The biotin-(strept)avidin technology ((strept)avidin refers
to either avidin or streptavidin), commonly referred to as
molecular velcro, relies on the extraordinary affinity of
biotin for either avidin or streptavidin (Ka ,1014 M 21) [1].
This remarkable affinity has been exploited for more than
20 years in analytical biology, immunolabelling, affinity
targeting, and biomolecular purification [2–5]. More re-
cently, this technology has been applied in bioengineering
and biomedicine, notably in drug targeting [4].
Inspired by Whitesides’ work, our group has produced
artificial metalloenzymes for enantioselective catalysis by
anchoring an organometallic biotinylated catalyst inside
(strept)avidin [6–9]. The biotin-(strept)avidin technology
relies on the fact that derivatization of the valeric acid side
chain of biotin does not interfere too significantly with the
biotin-(strept)avidin affinity [1]. With the aim of performing
random mutations of the (strept)avidin gene to produce
selective artificial metalloenzymes, we require a con-
venient method to rapidly identify the functional (strept)a-
vidin mutants from the crude cell extracts. Neither anti-
bodies nor Coomassie blue staining fulfill these require-
ments.
Bayer and Wilchek [10, 11] reported that biotin stabilizes
the tetrameric structure of (strept)avidin. This stabilization
effect is observed at elevated temperatures and in SDS-
PAGE [11]. This thermal stabilization is currently exploited
as a tool for (strept)avidin characterization [12]. In the
present study, we show that this stabilization effect can
be extended to a biotinylated molecule which can be
readily detected by optical methods.
Biotin-4-fluorescein is a convenient, commercially avail-
able probe used to quantify the number of active sites of
purified biotin-binding proteins or to estimate their con-
centration in complex biofluids [13]. The quantification
principle of this assay is based on the (partial) fluores-
cence quenching of biotin-4-fluorescein upon incorpora-
tion in (strept)avidin. In this work, we determine the ther-
mal stabilization extent of the tetrameric structure of
streptavidin, complexed with biotin-4-fluorescein. The
biotin-4-fluorescein streptavidin adduct is detectable
using a UV transilluminator and a comparison with Coo-
massie blue staining is made to determine the detection
limits of both techniques. We apply the biotin-4-fluores-
cein on bacterial extracts of Escherichia coli expressing
different streptavidin mutants and analyze these extracts
in nondenaturing SDS-PAGE. We show that the presence
of a fluorescent band in the gel, exposed to UV light, is
correlated with the functionality of the mutants.
2 Materials and methods
2.1 Materials
Chemicals and media were purchased from Acros-
Brunschwig (Basel, Switzerland), Sigma, Fluka (Buchs,
Switzerland), or Gibco-Invitrogen (Basel, Switzerland).
The 2-iminobiotin-agarose was provided by Affiland (Ans-
Liège, Belgium). SDS-PAGE analysis was carried out with
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Bio-Rad equipment (Bio-Rad, Reinach, Switzerland) [14].
The molecular mass of the expressed streptavidin
mutants was determined by electrospray ionization mass
spectrometry (ESI-MS) (VG platform mass spectrometer,
Micromass instruments, Manchester, UK). The function-
ality of the recombinants proteins was assessed by
fluorimetric titration using biotin-4-fluorescein (Molecular
Probes – Juro, Luzern, Switzerland) [13].
2.2 Production of recombinant streptavidin
Heat-shock competent BL21(DE3)pLysS E. coli strain
(Novagen-Juro, Luzern, Switzerland) were transformed
by pET11b-SAV plasmid containing a gene encoding for
recombinant streptavidin fused with the T7-tag [15–18].
Transformed bacteria were plated on Luria broth (LB)
dishes [19] containing ampicilline (60 mg/mL), chloram-
phenicol (34 mg/mL) and glucose (1% w/v), and further
incubated overnight at 377C. The culture medium (150 mL
total, 20 g/L bactotryptone, 2 g/L Na2HPO4, 1 g/L
KH2PO4, 8 g/L NaCl, 15 g/L bacto yeast extract) contain-
ing ampicilline (60 mg/mL), chloramphenicol (34 mg/mL),
and glucose (1% w/v) were inoculated with a single col-
ony. This preculture was incubated overnight on an orbital
shaker (377C, 230 rpm). High-cell-density fermentation
was performed in a 15 L fermentor. The culture medium
(10 L) containing ampicilline (60 mg/mL), chloramphenicol
(34 mg/mL), and glucose (0.4% w/v), was inoculated with
the whole preculture. The cells were grown at 377C until
an OD600 ,1.4–1.6 was reached. Then, isopropyl b- D -1-
thiogalactopyranoside (IPTG) was added (final con-
centration, 0.4 mM ). After 3 h induction, the cells were
harvested (centrifugation at 36006g, 10 min, 47C). The
pellet was washed with Tris-suspension buffer (50 mL,
20 mM Tris-HCl, pH 7.4, 0.02% w/v sodium azide, 10 mM
MgCl2) and recentrifuged (36006g, 10 min, 47C). The
supernatant was discarded and the pellet was frozen at
2807C until purification.
2.3 Protein purification
The pellet was thawed and resuspended in Tris-suspen-
sion buffer (50 mL). Lyophilized DNase I (5 mg; Roche,
Rotkreuz, Switzerland) was added and incubated at 257C
until total degradation of nucleic acids. The volume of
resuspension was completed with 6 M guanidium hydro-
chloride pH 1.5 (final volume, 400 mL) and the sample was
dialyzed against the same solution to fully denature the
protein (24 h, room temperature (RT)). Two consecutive
dialyseswere performed (20mM Tris-HCl, pH7.4, followed
by 50 m M Na2CO3, pH 9.8, 0.5 M NaCl) to renature the
streptavidin and to prepare the proteic extract for affinity
chromatography. The proteic extract was then centrifuged
(200006g, 30 min, 47C), the pellet was washed with the
above carbonate buffer (100 mL) and recentrifuged in the
same conditions. The supernatant was filtered (0.45 mm
filter) and applied on a 2-iminobiotin agarose column
equilibrated at pH 9.8 (50 mM Na2CO3, 0.5 M NaCl). Pure
streptavidin was eluted with acetic acid (0.1 M pH 2.9),
immediately dialyzed against the Tris-buffer (10 mM Tris-
HCl, pH 7.4, 24 h, 47C), against distilled water and finally
against bidistilledwater. Followinga final filtration (0.22 mm
filter), the purifiedproteinwas frozen at2807C, lyophilized,
and stored at 47C until use. The molecular weight of the
purified protein was assessed by ESI-MS.
2.4 Site-directed mutagenesis
The streptavidin mutants’ genes were obtained using the
QuickChange Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA, USA). The PCR reaction was performed in
the presence of DMSO (5%). The cycle conditions were:
initial denaturation (947C, 5 min), followed by 16 cycles of
1 min at 947C; 1 min at 657C; 15 min at 687C. The final
extension was performed at 687C for 1 h.
After analysis, the template (nonmutated plasmid) was
digested by DpnI (1 h at 377C). An aliquot was used to
transform the XL1-blue E. coli strain. Plasmids were
extracted from bacteria using WizardPlus Miniprep Sys-
tem (Promega-Catalys, Wallisellen, Switzerland) and were
sequenced by Synergene (Schlieren, Switzerland).
2.5 Minicultures of streptavidin mutants
Heat-shock competent BL21(DE3)pLysS E. coli strain
(Novagen – Juro) was transformed by wild-type, empty or
mutant plasmids and plated on LB dishes containing
ampicilline (60 mg/mL), chloramphenicol (34 mg/mL), and
glucose (1% w/v), and further incubated overnight (377C).
The culture medium (1 mL) containing the antibiotics and
glucose in the same proportions was inoculated with a
single colony and incubated overnight at 377C. This pre-
culture (80 mL) was used to inoculate the culture medium
(4 mL) containing antibiotics in same proportions and glu-
cose (0.4% w/v) in 50 mL falcon tubes. After 3 h of incu-
bation at 377C under orbital shaking, IPTG was added
(final concentration, 0.4 mM ). The bacteria were grown for
2 h and centrifuged (5 min, 50006g). The culture medium
was removed and the pellet was stored at2207C until use.
2.6 Nondenaturing and denaturing SDS-PAGE
Each experiment was performed in 16% acrylamide-
bisacrylamide separating gels. The stacking gels con-
tained 5% of acrylamide-bisacrylamide. The denatur-
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ing conditions refer to heating the samples in the
presence of a denaturing loading buffer (50 mM Tris-
HCl, pH 6.8, 1% w/v SDS, 2% v/v b-mercaptoethanol,
10% w/v sucrose, 0.006% w/v bromophenol blue).
The nondenaturing conditions refer to heating the
samples without the loading buffer. Following this
treatment, the nondenaturing loading buffer (same
formulation as above except for SDS and b-mercap-
toethanol) was added prior to loading the samples in
the gels.
2.7 Heat stability experiments
The purified streptavidin (12 mg) was combined with bio-
tin-4-fluorescein (1 mL of a 0.6 mM stock solution) and
incubated under gentle stirring (15 min, RT) to ensure
complete binding of the biotinylated compound. The
samples were then incubated at the selected temperature
for 15 min and were then loaded in SDS-PAGE. Following
the migration, the gel was stained by Coomassie Brilliant
Blue [19].
2.8 Determination of the detection limit of
streptavidin with biotin-4-fluorescein
A solution of purified wild-type streptavidin (10 mg/mL)
was combined with biotin-4-fluorescein (1 mL of a 0.6 mM
stock solution), incubated 15 min at RT under gentle stir-
ring, and successively diluted to obtain a concentration
ranging from 10 mg to 20 ng (in 15 mL). The nondenaturing
loading buffer was added and the protein was loaded on
SDS-PAGE. After migration, the gel was immediately an-
alyzed by UV exposition in a transilluminator. For com-
parison, the gel was stained with Coomassie Brilliant
Blue.
2.9 Analysis of the minicultures
The cell pellets were thawed and resuspended in the
Tris-suspension buffer (600 mL) containing DNase I (1 mL
of a stock solution at 1 mg/mL), and incubated until the
nucleic acids were thoroughly digested. The samples
were centrifuged (5 min, 16 0006g, RT) and the super-
natants were transferred in to a new tube. The super-
natants (12 mL) were combined with biotin-4-fluorescein
(1 mL of 0.6 mM ) and equilibrated under gentle stirring
(15 min, RT). The nondenaturing loading buffer was then
added and the samples were loaded in SDS-PAGE.
Revealing was first performed by UVexposition and then
by Coomassie Brilliant Blue staining.
3 Results and discussion
3.1 Production and mutation of recombinant
streptavidin
Using the protocol described above, we routenely pro-
duce wild-type and mutant streptavidin at high con-
centration levels (up to 200 mg of protein per liter cell
culture) in Escherichia coli. The DNA sequencing and
mass spectral analysis of the protein unambiguously
confirm the gene sequence and the molecular weight of
the corresponding purified protein [16].
3.2 Stabilization of streptavidin by
biotin-4-fluorescein in denaturing and
nondenaturing SDS-PAGE
As biotin is not readily detectable under UV-visible illumi-
nation, we sought for biotinylated molecules which can
be revealed by this simple procedure [11]. For this pur-
pose, we tested the biotinylated chromophore biotin-4-
fluorescein (Fig. 1). Figure 2A depicts the behavior of wild-
type streptavidin in nondenaturing SDS-PAGE. The pro-
tein appears as a tetramer with a small quantity of oligo-
tetramers at low temperatures. At 727C, the oligote-
tramers start to disappear with the concomitant appear-
ance of monomers (and dimers to a small extent). The
presence of SDS during the heat-denaturation con-
tributes to decrease the denaturation temperature to 637C
(Fig. 2B).
Figure 1. Structure of (A) (1)-biotin and (B) biotin-4-fluo-
rescein.
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Figure 2. SDS-PAGE of (A) apo-streptavidin under non-
denaturing conditions, (B) apo-streptavidin under dena-
turing conditions, and (C) streptavidin complexed with
biotin-4-fluorescein under nondenaturing conditions
exposed to increasing temperatures. The proteins were
incubated 15 min at RT with or without biotin-4-fluores-
cein and heated at the indicated temperature for 15 min.
M, BioRad Prestained Protein Marker Broad Range;
1ND, nondenatured apostreptavidin; 1D, denatured
apostreptavidin. The gels were stained with Coomassie
Brilliant Blue.
As shown by Wilchek and co-workers, the presence of
biotin stabilizes the tetrameric form of streptavidin [11]:
the tetramer denaturation occurs above 1007C. The same
trend is observed with biotin-4-fluorescein (Fig. 2C), but
the tetramer to monomer transition appears at lower
temperatures (i.e., 727C in the presence of SDS and 827C
under nondenaturing conditions).
3.3 Comparison of the detection limit of the
protein by Coomassie blue staining and by
biotin-4-fluorescein under nondenaturing
conditions
In order to detect streptavidin in SDS-PAGE using an UV
transilluminator, we exploit the biotin-4-fluorescein fluo-
rescent properties (lex = 485 nm, lem = 525 nm). Figure 3
presents a comparison between the fluorescence detect-
Figure 3. Comparison of the detection limit of streptavidin
complexed with biotin-4-fluorescein in nondenaturing
SDS-PAGE, by fluorescence andCoomassie blue staining.
Decreasing amounts of the biotin-4-fluorescein streptavi-
din adduct were incubated 15 min at RTand loaded in the
SDS-PAGE. The same gel was analyzed in UV transillumi-
nator (A) and then stained with Coomassie Blue (B).
ed upon UV transillumination (Fig. 3A) and Coomassie
blue staining (Fig. 3B) of samples with decreasing quan-
tities of purified streptavidin containing biotin-4-fluores-
cein, loaded in an SDS-PAGE. In both cases, the strepta-
vidin appears as a tetramer with small amounts of oligo-
tetramer. The presence of a fluorescence signal under the
UV transilluminator clearly shows that biotin-4-fluorescein
remains bound to streptavidin during migration on the gel.
As can be judged from Fig. 3, the detection limit for both
methods is comparable.
Upon incorporation in (strept)avidin, the fluorescence of
biotin-4-fluorescein is partially quenched [13]. However,
sufficient fluorescence is maintained to allow the detec-
tion of the biotin-4-fluorescein streptavidin adduct in the
gel without any further time-consuming manipulation
after electrophoresis. In contrast with Coomassie blue
staining or Western blotting, this detection provides a
functional screen for the biotin-binding activity. These
results suggest that the incorporation of biotin-4-fluores-
cein does not induce any significant shift in the position of
the bands corresponding to the tetramer (Fig. 3B, lanes
1ND and 10 mg). As molecular weight markers cannot be
detected using UV-transillumination, we rely on the use of
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purified functional wild-type streptavidin, complexed with
biotin-4-fluorescein as positive size marker (Fig. 3B, lanes
1ND and 10 mg).
3.4 Detection of functional streptavidin mutants
in bacterial extract
The biotin-binding activity of streptavidin present in com-
plex biofluids is detectable exploiting the fluorescence of
biotin-4-fluorescein [13]. We adapted this protocol to
SDS-PAGE conditions as it can readily be fitted to high-
throughput screening of DNA-shuffled mutants. For this
purpose, biotin-4-fluorescein was added to bacterial
extracts expressing four different streptavidin isoforms:
wild-type, V47G, K80G, and N81P. Each mutant displays
different characteristics compared to the wild-type pro-
tein. The V47G mutant is a functional protein which proved
difficult to quantify in a cuvette using the biotin-4-fluores-
cein protocol (Fig. 4) [13]. However, it is readily purified by
affinity chromatography on iminobiotin, suggesting that
this mutant indeed has a strong affinity for (imino)biotin.
The residue V47 is located in loop 3,4 close to the biotin-
binding site. Its backbone amide has an H-bonding inter-
action with S45 which is in contact with biotin [20]. The
production of N81P proved problematic as it was expres-
sed exclusively in the form of inclusion bodies. Residue
N81 is located in loop 5,6 close to the biotin binding site.
Substitution of an amino acid by a proline is known to have
a profound effect on loop conformation [21]. The mutant
K80G was expressed mainly as inclusion bodies but, in
contrast to N81P, it can be purified by affinity chromatog-
raphy and quantified using the biotin-4-fluorescein titra-
tion protocol. The K80G mutation was designed to sup-
press a positive charge in loop 5,6 and to introduce flex-
ibility, thus possibly influencing the adjacent W79 which is
involved in biotin-streptavidin interaction [22].
Figure 4. Biotin-binding activity assay for (n) purified
recombinant wild-type streptavidin and (d) V47G mutant.
The titrationwas performed with 50 mL of a 2 mM protein so-
lution.
Figure 5 displays the SDS-PAGE as revealed by UV
transilluminator, containing different mutants treated
with biotin-4-fluorescein prior to loading. In lane 4, the
wild-type streptavidin appears as a fluorescent band in
the top of the gel, suggesting the presence of a tetra-
meric protein. As a blank, lane 5 displays the bacterial
extract (treated with biotin-4-fluorescein) from a clone
devoid of the streptavidin gene. No fluorescence is
observed, thus demonstrating that biotin-4-fluorescein
does not interact with other proteins or bacterial frag-
ments. The streptavidin mutant V47G displays the same
pattern as wild-type streptavidin (lane 6), suggesting
that indeed the mutant is functional. This observation,
combined with the fact that the titration protocol is not
applicable to this mutant, suggests that biotin-4-fluo-
rescein is indeed incorporated within V47G but its fluo-
rescence is not quenched (Fig. 4). The inability of N81P
to bind biotin derivatives is confirmed as no band
appears in lane 7. This observation suggests that the
inactivity of the mutant is due to misfolding. Although
not functional, this mutant is revealed by Western blot.
In lane 8, the mutant K80G exhibits a retarded migration
compared to the other proteins with similar molecular
weight. This migration pattern was further confirmed
using purified K80G (lane 9), thus excluding an effect
due to bacterial fragments. Biotin-4-fluorescein applied
to a protein extract from E. coli expressing streptavidin
mutants confirms that this fluorophore is a useful tool
that allows to quickly asses the biotin-binding properties
of streptavidin mutants prior to large-scale production.
Moreover, no interference with other proteins or other
cellular fragments is observed.
Figure 5. UV revealing of biotin-4-fluorescein streptavi-
din-mutants adducts present in bacterial extracts. Bio-
tin-4-fluorescein (1 mL of a 0.6 mM solution) was applied
to the E. coli soluble extract. Samples were equilibrated
with gentle stirring during 15 min and loaded in SDS-
PAGE (nondenaturing conditions). Lanes 1 and 2, non-
denatured and denatured purified wild-type streptavidin;
lane 3, BioRad Prestained Protein Marker Broad Range;
lanes 4–8, bacterial extracts of E. coli transformed with
wild-type plasmid (4), empty plasmid (5), V47G mutant
(6), N81P (7), and K80G (8); lane 9, purified K80G
mutant.
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4 Concluding remarks
Biotin has long been known to favor the folding of
(strept)avidin under various denaturing conditions pro-
vided by (i) extreme pH values, (ii) high concentrations of
urea or of guanidium hydrochloride, (iii) detergents, and
(iv) high temperatures [23, 24]. The results presented herein
shed light on the stabilizing effect of a biotinylated chro-
mophore towards thermal- and detergent-assisted dena-
turation of streptavidin as reflected by the electrophoretic
behavior of the streptavidin in SDS-PAGE. Most impor-
tantly, thebiotin-4-fluorescein assay presented here allows
to assess the biotin-binding properties and to roughly esti-
mate the amount of functional streptavidin in a bacterial
extract without any interference caused by the presence of
cellular fragments. The behavior of four representative
streptavidin isoforms is presented, but this technique was
applied to over 20 mutants. The semiquantitative results,
concerning the state of aggregation and the activity, are
complementary to those obtained with other time-con-
suming detection protocols, such as Western blot and
titration of biotin-binding sites using a spectrofluorimeter.
We are currently using this protocol towards the develop-
ment of DNA-shuffled streptavidin genes.
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